MedPath

Study Of Use Of Pashanbhedadi Ghanvati In The Treatment Of Enlargement Of Prostate.

Phase 2
Not yet recruiting
Conditions
Benign prostatic hyperplasia withlower urinary tract symptoms,
Registration Number
CTRI/2020/11/029083
Lead Sponsor
Preeti Bhalke
Brief Summary

"This Study Is Randomized Open Labelled Controlled Clinical Trial Of Efficacy Of *Pashanbhedadi Ghanvati* In The Management Of *Vaatashthila*  With Special Reference To Benign Prostate Hyperplasia For 45 days And Follow Up And Assesment on 15th, 30th, 45th Day. This study is conducted as a compulsary part of PG course at single centre. The primary outcome is to find out *Pashanbhedadi Ghanvati* reduces the size of prostate and post void residual volume.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Male
Target Recruitment
36
Inclusion Criteria

Patients having prostate size 30 to 100 gram Patients having post void residual volume 50 to 200 ml Patients willing to participate in study Patients having mild 1 to 7 moderate 8 to 19 international prostate symptom score Patients with severe 20 to 35 international prostate symptom score with no other consequences of benign prostate Hyperplasia and reluctant for surgery.

Exclusion Criteria

Patients of malignant prostatic enlargement or prostatitis or uremia septicemia or renal failure Patients having other urological pathologies like nephrotic syndrome or glomerulo nephritis or chronic kidney diseases etc Increased serum creatinine and blood urea Patients having HIV or HBsAg or major systemic disorders like uncontrolled HTN or DM or PTB etc Patients participating in other clinical trials Patients having hematuria Patients with acute urine retention which needs surgical intervention Patients currently using any other form of medicle therapy for benign prostate hyperplasia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To find out how Pashanbhedadi Ghanvati reduces the prostate size and post void residual volume45 days
Secondary Outcome Measures
NameTimeMethod
To establish the better medicinal alternative in the management of VaatashthilaTo find out effects of Pashanbhedadi Ghanvati on the other symptoms of Vaatashthila

Trial Locations

Locations (1)

Government Ayurved College and Hospital Nanded

🇮🇳

Nanded, MAHARASHTRA, India

Government Ayurved College and Hospital Nanded
🇮🇳Nanded, MAHARASHTRA, India
Dr R H Amilkanthawar
Principal investigator
9890569621
drarajendrah@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.